View Older Stories View More Recent Stories

Mar 21, 2025 07:22AM AstraZeneca (AZN) and Harbour BioMed Enter Global Strategic Collaboration to Discover and Develop Next-Generation Therapeutic Antibodies

Mar 21, 2025 07:03AM AstraZeneca (AZN) to invest $2.5B in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

Mar 19, 2025 12:13PM TD Cowen Highlights AstraZeneca's (AZN) 'Attractive Valuation'; Stock Named Europe Best Ideas

Mar 17, 2025 08:14AM AstraZeneca (AZN) to acquire EsoBiotec

Mar 7, 2025 07:01AM AstraZeneca (AZN): IMFINZI (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement

Mar 3, 2025 08:00AM These 5 stocks are latest additions to Goldman's 'European Conviction List - Directors’ Cut' list

Feb 28, 2025 08:01AM AstraZeneca (AZN) reports ENHERTU Recommended for Approval in the EU by CHMP

Feb 26, 2025 07:00AM AstraZeneca (AZN) reports Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer w

Feb 21, 2025 04:00PM FINAL REMINDER AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts AstraZeneca PLC Investors to Participate in the Class Action Lawsuit

Feb 20, 2025 07:30PM AZN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 20, 2025 04:00PM FINAL AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AstraZeneca PLC Investors to Join the Class Action Lawsuit

Feb 20, 2025 03:24PM AZN FINAL DEADLINE ALERT: AstraZeneca (AZN) Investors with Losses Encouraged to Contact Hagens Berman Before Feb. 21, 2025 Deadline in Securities Class Action

Feb 20, 2025 06:33AM FibroGen (FGEN) Sells FibroGen China to AstraZeneca (AZN) for $160M

Feb 18, 2025 05:42PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 18, 2025 01:27PM AstraZeneca (AZN) Hit With US Class Action Lawsuit Over China Regulatory Probes - FT

Feb 18, 2025 01:05PM AZN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 17, 2025 01:14PM AZN DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 17, 2025 11:29AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 16, 2025 12:21PM AZN DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by th

Feb 15, 2025 08:16AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 14, 2025 05:45PM AZN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm -

Feb 14, 2025 04:30AM This pharma stock has rich catalyst path, attractive valuation: BofA

Feb 13, 2025 05:40PM AZN DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 13, 2025 01:26PM AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman

Feb 13, 2025 12:12AM UBS Upgrades AstraZeneca (AZN:LN) (AZN) to Buy

Feb 12, 2025 05:44PM AZN DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - A

Feb 12, 2025 06:00AM BofA Securities Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

Feb 12, 2025 05:45AM Morgan Stanley Starts AstraZeneca (AZN:LN) (AZN) at Overweight

Feb 11, 2025 03:18PM Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN

Feb 11, 2025 12:32PM ROSEN, A TOP RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 10, 2025 10:00AM This pharma stock offers 'best-in-class catalyst path': Goldman Sachs

Feb 10, 2025 05:32AM AstraZeneca (AZN:LN) (AZN) PT Lowered to GBP150.67 at Goldman Sachs

Feb 9, 2025 07:35AM Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN

Feb 8, 2025 01:32PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 7, 2025 12:12PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 6, 2025 05:42PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 6, 2025 05:14AM AstraZeneca (AZN) Tops Q4 EPS by 103c; offers guidance

Feb 3, 2025 06:47PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

Feb 3, 2025 05:48PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Jan 28, 2025 02:22PM AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman

Jan 28, 2025 03:14AM Berenberg Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN), Pipeline valuation gap looks compelling

Jan 27, 2025 12:57PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Jan 26, 2025 07:42AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Jan 23, 2025 05:06PM ROSEN, A LONGSTANDING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

Jan 23, 2025 02:18PM AstraZeneca (AZN) plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Jan 22, 2025 05:01PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

Jan 21, 2025 03:55PM AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman

Jan 21, 2025 09:48AM Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN

Jan 20, 2025 02:16PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

Jan 19, 2025 12:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN

View More Recent Stories View Older Stories